ArticleScientific reports2026
Deglycosylation induces a novel distal conformation in the mannose receptor CD206.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deglycosylation can disrupt protein structure and dynamics in ways that compromise function. In this study, we examine the structural and functional consequences of N-glycan removal in the mannose receptor CD206, a multi-domain lectin involved in innate immunity. Using atomistic molecular dynamics simulations and AlphaFold-predicted full-length models, we provide the first comprehensive structural and dynamical characterization of CD206, which remains unresolved by experimental methods. Our simulations reveal that deglycosylation enables access to a previously undescribed concave conformational state in the distal lectin domains CTLD7-8, in contrast to the glycosylated form, which remains restricted to a convex arrangement. Principal component and normal mode analyses show that this conformational switch is tightly linked to the presence of glycosylation in certain residues, which constrains receptor flexibility and reduces conformational sampling. While both conformations share an extended global architecture, they differ in curvature, potentially influencing ligand accessibility. Functional assays with α-D-mannopyranoside (MMA), a natural-occurring ligand of CD206, and the CD206-binding tumor-homing peptide mUNO show that deglycosylation weakens canonical ligand retention and exposes new interaction sites, including regions normally shielded by glycans. These findings suggest that altered glycosylation, as seen in pathological conditions like cancer, can reshape the receptor's conformational and binding landscape, ultimately influencing immune recognition and offering new opportunities for therapeutic targeting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.